These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8858270)
1. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry. Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270 [TBL] [Abstract][Full Text] [Related]
2. The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration. Decktor D; Houle JM; Pierce CH Am J Ther; 1998 Mar; 5(2):97-100. PubMed ID: 10099044 [TBL] [Abstract][Full Text] [Related]
3. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring. Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity. Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722 [TBL] [Abstract][Full Text] [Related]
5. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors. Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700 [TBL] [Abstract][Full Text] [Related]
6. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine. Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334 [TBL] [Abstract][Full Text] [Related]
7. Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity. Gardner JD; Ciociola AA; Robinson M; McIsaac RL Aliment Pharmacol Ther; 2002 Jul; 16(7):1317-26. PubMed ID: 12144582 [TBL] [Abstract][Full Text] [Related]
8. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo. Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196 [TBL] [Abstract][Full Text] [Related]
9. [Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease]. Ivanov AN; Iakovenko EP; Iakovenko AV Eksp Klin Gastroenterol; 2004; (4):16-20, 107. PubMed ID: 15568661 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring. Takeda H; Hokari K; Asaka M J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616 [TBL] [Abstract][Full Text] [Related]
11. Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects. Echizen H; Shoda R; Umeda N; Ishizaki T Clin Pharmacol Ther; 1988 Dec; 44(6):690-8. PubMed ID: 2904311 [TBL] [Abstract][Full Text] [Related]
12. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine. Netzer P; Eschenmoser K; Halter F; Inauen W Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975 [TBL] [Abstract][Full Text] [Related]
13. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers. Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic interpretation of 24-hour intragastric pH-metry using a pattern recognition method. Hunyady B; Juricskay I; Pakodi F; Horváth C; Mózsik G Aliment Pharmacol Ther; 1996 Jun; 10(3):353-8. PubMed ID: 8791963 [TBL] [Abstract][Full Text] [Related]
15. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine. Fullarton GM; Macdonald AM; McColl KE Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675 [TBL] [Abstract][Full Text] [Related]
16. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade. Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465 [TBL] [Abstract][Full Text] [Related]
17. Suppression of gastric acid secretion by intravenous administration of famotidine in children. Treem WR; Davis PM; Hyams JS J Pediatr; 1991 May; 118(5):812-6. PubMed ID: 2019939 [TBL] [Abstract][Full Text] [Related]
18. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects. Suzuki T; Yamaguchi T; Odaka T; Kobayashi M; Seza A; Kouzu T; Yokosuka O Aliment Pharmacol Ther; 2008 Jan; 27(1):66-71. PubMed ID: 17922801 [TBL] [Abstract][Full Text] [Related]
19. Low-dose famotidine and effervescent cimetidine in healthy subjects: a placebo-controlled overnight pH study. Reilly TG; Grimley CE; Usselmann B; Cottrell J; Mann SG; Raskin S; Nwokolo CU Aliment Pharmacol Ther; 1998 May; 12(5):469-74. PubMed ID: 9663728 [TBL] [Abstract][Full Text] [Related]
20. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine. Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]